Life Science Innovation Dependent on Venture Capital, New Report Asserts
VC Investment in Biotech and Medical Device Companies Accelerates Time to Market, Extends and Improves the Lives of Millions
03-Dec-2004 -
More than 100 million (1 of every 3) Americans have benefited from venture-backed medical
innovations developed during the past 20 years, according to a new qualitative
research report issued today by Pacific Bridge Life Sciences and THE WEINBERG
GROUP. The report entitled, "Patient Capital: ...
Amgen
arthritis
asthma
+9